echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > AD: Features and significance of neurologic examination results in autosomal dominant Alzheimer's patients

    AD: Features and significance of neurologic examination results in autosomal dominant Alzheimer's patients

    • Last Update: 2022-09-30
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    ADAD autosomal dominant Alzheimer's disease (ADAD) is a rare single-genotype of Alzheimer's disease
    .


    However, the average age of ADAD and sporadic AD at clinical onset is different: the average age of onset of ADAD is in their 40s, while sporadic AD begins more often in their 70s
    .


    Since β-amyloid precursor protein (APP), progerin-1 (PSEN1) and progerin-2 (PSEN2) are the three main pathogenic genes that cause ADAD, 17 research centers from around the world have joined forces to explore the frequency and significance of neurological examination results in gene mutation carriers in AD to further confirm the neurological examination characteristics
    of Alzheimer's disease.


    The results found that the frequency of neurological examination abnormalities in the carriers of gene mutations was 65.


    In addition to this, the mutation carriers experienced a faster decline in cognitive function and greater
    atrophy of the parietal temporal lobe and hippocampus.


    : ,
    。 Video Mini Program like, tap twice to cancel like in viewing, tap twice to cancel in viewing

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.